IDÉLALISIB
SELECT categories.* FROM (SELECT DISTINCT CAST(SUBSTRING(members.anchor, 10) AS UNSIGNED) AS target FROM yacs_members AS members WHERE (members.member LIKE 'article:6905') AND (members.anchor LIKE 'category:%')) AS ids, yacs_categories AS categories WHERE (categories.id = ids.target) AND (categories.active='Y') AND ((categories.expiry_date is NULL) OR (categories.expiry_date <= '0000-00-00 00:00:00') OR (categories.expiry_date > '2024-12-25 02:56:13')) ORDER BY rank, title, edit_date DESC LIMIT 0,40
1064: You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near ', title, edit_date DESC LIMIT 0,40' at line 1
SELECT sections.* FROM yacs_sections AS sections WHERE (sections.anchor='' OR sections.anchor IS NULL) AND (sections.active='Y') AND (sections.index_map = 'Y') AND ((sections.activation_date is NULL) OR (sections.activation_date <= '2024-12-25 02:56:13')) AND ((sections.expiry_date is NULL) OR (sections.expiry_date <= '0000-00-00 00:00:00') OR (sections.expiry_date > '2024-12-25 02:56:13')) ORDER BY rank, title, edit_date DESC LIMIT 0,8
1064: You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near ', title, edit_date DESC LIMIT 0,8' at line 1
- en monothérapie, pour la poursuite du traitement de deuxième intention ou plus de la leucémie lymphoïde chronique chez les personnes dont la maladie n’a pas progressé pendant un traitement de 8 cycles combinant l’idélalisib et le rituximab.
La durée maximale de chaque autorisation est de 6 mois.
Lors des demandes pour la poursuite du traitement, le médecin devra fournir la preuve d’un effet clinique bénéfique par l’absence de progression de la maladie.